Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP865324.RAXRRRRhg0lyKnFfH5aB7OHcdYOUkSdO0KLvQHEot2GcY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP865324.RAXRRRRhg0lyKnFfH5aB7OHcdYOUkSdO0KLvQHEot2GcY130_assertion type Assertion NP865324.RAXRRRRhg0lyKnFfH5aB7OHcdYOUkSdO0KLvQHEot2GcY130_head.
- NP865324.RAXRRRRhg0lyKnFfH5aB7OHcdYOUkSdO0KLvQHEot2GcY130_assertion description "[PIK3CA mutations are present in approximately 40% of luminal BCs but are not an independent predictor of outcome in the context of endocrine therapy, whereas RAS/RAF mutations are rare inluminal BC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865324.RAXRRRRhg0lyKnFfH5aB7OHcdYOUkSdO0KLvQHEot2GcY130_provenance.
- NP865324.RAXRRRRhg0lyKnFfH5aB7OHcdYOUkSdO0KLvQHEot2GcY130_assertion evidence source_evidence_literature NP865324.RAXRRRRhg0lyKnFfH5aB7OHcdYOUkSdO0KLvQHEot2GcY130_provenance.
- NP865324.RAXRRRRhg0lyKnFfH5aB7OHcdYOUkSdO0KLvQHEot2GcY130_assertion SIO_000772 25071141 NP865324.RAXRRRRhg0lyKnFfH5aB7OHcdYOUkSdO0KLvQHEot2GcY130_provenance.
- NP865324.RAXRRRRhg0lyKnFfH5aB7OHcdYOUkSdO0KLvQHEot2GcY130_assertion wasDerivedFrom befree-20150227 NP865324.RAXRRRRhg0lyKnFfH5aB7OHcdYOUkSdO0KLvQHEot2GcY130_provenance.
- NP865324.RAXRRRRhg0lyKnFfH5aB7OHcdYOUkSdO0KLvQHEot2GcY130_assertion wasGeneratedBy ECO_0000203 NP865324.RAXRRRRhg0lyKnFfH5aB7OHcdYOUkSdO0KLvQHEot2GcY130_provenance.